Question 1 of 5
Scenario B. (a) Define a cell-cycle checkpoint. (b) State the relationship between cyclins and CDKs in cycle control. (c) Give one reason checkpoints matter for genome integrity.
Responses receive AI feedback against a rubric after submission. Scores are practice estimates.
Scenario B. (a) Define a cell-cycle checkpoint. (b) State the relationship between cyclins and CDKs in cycle control. (c) Give one reason checkpoints matter for genome integrity.
Scenario B. (a) Describe what happens conceptually when cyclin levels/activity change relative to CDK partners (no specific pair names). (b) Explain how that change can gate progression. (c) Critique a study plan that only memorizes named growth factors for this topic.
Scenario B. Compare a cell that pauses at a checkpoint with a cell that lacks that checkpoint. (a) State the difference in progression. (b) Predict which is safer after detecting incomplete DNA replication. (c) Provide reasoning.
Scenario B. (a) Identify cancer as a possible result of cycle disruption. (b) Identify apoptosis as another possible result. (c) Explain how the two outcomes differ for the affected cell.
Scenario B. A tumor suppressor pathway that triggers apoptosis after damage is inactivated. (a) Predict the immediate fate of a severely damaged cell compared with a cell that retains the pathway. (b) Predict a tissue-level risk over many divisions. (c) Relate your predictions to CED essential knowledge on cycle disruption.